DAVAO CITY, PHILIPPINES — For patients living with Generalized Pustular Psoriasis (GPP), the fight to stay alive has too often meant waiting too long, traveling too far, and suffering in silence. But that changes today.
On July 30, Psoriasis Philippines (PsorPhil) and the Southern Philippines Medical Center (SPMC) launched Mindanao’s second GPP Care Network. This formal partnership, sealed through a Memorandum of Understanding, brings focused care, expert training, and patient support to a region that has lacked access to specialized treatment for too long.
“This partnership is a lifeline,” said Josef De Guzman, PsorPhil Founder. “It means faster diagnoses, expert local care, and hope for patients who once felt invisible.”
TAGUM CITY, Philippines – July 28, 2025 – A significant stride forward in the fight against a rare and devastating immune-mediated inflammatory chronic disease was made yesterday as patient advocacy group Psorphil and the Davao Regional Medical Center (DRMC) formalized a powerful partnership. The signing of a Memorandum of Understanding (MOU) marks the establishment of the pioneering GPP Care Network, a dedicated initiative poised to transform the care landscape for patients with Generalized Pustular Psoriasis (GPP) in Mindanao and beyond.
The ceremony, held at DRMC, brought together key leaders committed to addressing the critical unmet needs of GPP patients. This rare condition, characterized by widespread, painful flares of sterile pustules, high fever, and systemic inflammation, is not only physically debilitating but also life-threatening. Patients often face agonizing delays in diagnosis, limited access to specialized care, profound isolation, and significant stigma.
Psoriasis Philippines (PsorPhil) has officially signed a Memorandum of Understanding (MOU) with Valenzuela Medical Center (VMC), marking a historic partnership as the 5th hospital to join the Generalized Pustular Psoriasis (GPP) Care Network. This collaboration is a significant step toward advancing quality care for individuals living with GPP in the CaMaNaVa and Central Luzon.
La Union – On April 28, 2025, Psoriasis Philippines (Psorphil) and the Ilocos Training and Regional Medical Center (ITRMC) signed a Memorandum of Understanding, opening new doors for patients battling Generalized Pustular Psoriasis (GPP).
The signing ceremony gathered key ITRMC leaders: Dr. Joseph Patrick Patricio (Rheumatology), Dr. Manuel C. Manis (Head of Internal Medicine), and Dr. Jocelyn Guideng-Mangugan (Dermatology). (Not in photos: Dr. Eduardo Badua III, FPSP, Medical Center Chief II)
Psorphil’s team was led by Founding CEO Josef De Guzman, joined by board members Dominador Delos Santos III and Paul Michale Cleofas, Moderator Christopher Tinaan, La Union Chapter President Rosalinda Pundal-Borja, and Chapter Adviser, Former NDRRMC Region 1 Director Melchito Castro. (Not in photos are Psorphil President Paul Albert Mendoza and Secretary Emmylou Casanova, the global face of GPP).
GPP is a rare, severe, and life-threatening form of psoriasis. It causes widespread painful pustules across the body, often leading to hospitalization and even death if left untreated. Because of its rarity, GPP is frequently misunderstood and misdiagnosed, leaving patients isolated and vulnerable.
The GPP Network Project, led by Psorphil, aims to build partnerships with hospitals and doctors nationwide to create a referral and support system for GPP patients. It also works to raise awareness, improve early diagnosis, and ensure faster access to specialized care.
Psorphil, founded in 2005, is the largest psoriasis patient organization in the Philippines. It has helped push critical healthcare policy reforms and become a trusted voice for psoriatic patients at home and abroad.
Patients and families battling GPP now have a reason to hope. This partnership will save more lives, and fewer will suffer in silence.
To learn more about this initiative, contact Psorphil at This email address is being protected from spambots. You need JavaScript enabled to view it. or visit www.psorphil.org.